- Home
- HCI vs TXG Comparison
HCI vs TXG Comparison
Compare HCI & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HCI | TXG |
|---|---|---|
| Founded | 2006 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.1B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | HCI | TXG |
|---|---|---|
| Price | $173.35 | $22.02 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 14 |
| Target Price | ★ $230.00 | $15.61 |
| AVG Volume (30 Days) | 129.7K | ★ 2.3M |
| Earning Date | 02-26-2026 | 02-11-2026 |
| Dividend Yield | ★ 0.91% | N/A |
| EPS Growth | ★ 32.29 | N/A |
| EPS | ★ 15.80 | N/A |
| Revenue | ★ $816,578,000.00 | $641,814,000.00 |
| Revenue This Year | $19.65 | $4.91 |
| Revenue Next Year | $9.97 | N/A |
| P/E Ratio | $11.14 | ★ N/A |
| Revenue Growth | ★ 8.75 | 1.92 |
| 52 Week Low | $115.65 | $6.78 |
| 52 Week High | $210.50 | $21.50 |
Technical Indicators
Market Signals| Indicator | HCI | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 38.27 | 70.92 |
| Support Level | $171.30 | $20.01 |
| Resistance Level | $180.34 | $21.50 |
| Average True Range (ATR) | 5.86 | 1.33 |
| MACD | -1.05 | 0.34 |
| Stochastic Oscillator | 5.33 | 99.13 |
Price Performance
Historical ComparisonAbout HCI HCI Group Inc.
HCI Group Inc is engaged in the property and casualty insurance business through two Florida domiciled insurance companies, Homeowners Choice Property & Casualty Insurance Company (HCPCI) and TypTap Insurance Company (TypTap). Both HCPCI and TypTap are authorized to underwrite various homeowners' property and casualty insurance products and allied lines business in the state of Florida and other states. The operating segments of the group are insurance operations, TypTap Group, reciprocal exchange operations, real estate operations, and corporate and other. It derives key revenue from the HCPCI Insurance operation segment.
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).